Patients receied 20,000 IU of epoetin alfa subcutaneously eery 2 wk for up to 27 wk, with dosage adjustments permitted after 4 wk of treatment.

• 这个标签公开，多中心，单一目的的试验观察在起始治疗阶段每两周注射1次重组人红细胞生成素20,000IU的效果。